Community-based HIV testing, same-day ART start, and decentralized monitoring and ART refills could increase viral suppression, particularly among priority groups who engage less in clinic-based HIV care, such as men who are more likely to have detectable HIV viral load.
We conducted a multi-site, household randomized trial of community-based ART compared to clinic services in rural and peri-urban areas of Sheema District, Uganda, and KwaZulu Natal, South Africa – the Delivery Optimization for ART (DO ART) Study. Community-based HIV testing was conducted at home and in mobile vans. People living with HIV (PLWH) who were not on ART with CD4>100 cell/mL were eligible for randomization to: 1) same-day community-based ART start with quarterly monitoring and ART refills through mobile vans, 2) ART start at the clinic with monitoring and refills through mobile vans in the community (hybrid approach); or 3) clinic-based ART (standard of care). The primary outcome was HIV viral suppression at 12 months, assessed by modified intent to treat analysis using regression analysis; testing first for superiority and then non-inferiority (relative 5%) if not superior.
Between May 2016 and March 2019, 1,531 PLWH not on ART were randomized: 708 (46%) were men and 36% were <30 years. Retention at 12 months was 95%. Compared to standard clinic care, community-based ART increased viral suppression (63% vs. 74%, RR=1.18, 95% CI: 1.07-1.29) and the hybrid approach was non-inferior (63% vs. 68%, RR=1.08, 95% CI: 0.98-1.19, p=0.005 for non-inferiority). Both community strategies significantly increased viral suppression among men: community-based ART (73%, RR=1.34, 95% CI: 1.16-1.55) and hybrid approach (66%, RR=1.19, 95% CI: 1.02-1.40), compared to standard of care (54%). Viral suppression was similar for men (73%) and women (75%) in the community ART arm – compared to 54% for men and 73% for women in the clinic arm.
Among PLWH who were not on ART, community-based HIV testing, same-day ART initiation, mobile van monitoring and ART resupply, significantly increased viral suppression compared to clinic-based ART. The UNAIDS 90-90-90 goal of 73% suppression was met for men and women in the community-based ART arm, eliminating disparities in viral suppression by gender. Combining decentralized ART initiation and refill is an effective strategy to increase viral suppression which should be implemented and evaluated in different contexts and populations who are not virally suppressed.